Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,240,840
New position
Shares Held
8,003
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#351
of 1,022 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Massar Capital Management, LP holds $9,813,886 across 6 Diagnostics & Research names. LH ranks #3 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
19,073 | $3,353,605 | |
| 2 | DGX |
Quest Diagnostics Inc
|
10,637 | $2,254,512 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
8,003 | $2,240,840 | |
| 4 | VCYT |
Veracyte, Inc.
|
14,149 | $830,970 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
1,220 | $646,099 | |
| 6 | NEO |
Neogenomics Inc
|
33,438 | $487,860 |
All Filings in LH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,240,840 | 8,003 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||